(Q40622683)

22 September 2017

N-butyldeoxynojirimycin inhibits murine melanoma cell ganglioside metabolism and delays tumor onset (English)

1 reference

22 September 2017

Michael Guerrera

1

1 reference

PubMed ID

14580684

22 September 2017

Stephan Ladisch

series ordinal

2

1 reference

PubMed ID

14580684

22 September 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

22 September 2017

1 reference

22 September 2017

201

1 reference

22 September 2017

1

1 reference

22 September 2017

31-40

1 reference

Shedding of gangliosides from tumor cells depends on cell density

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Detection of a tumour-associated ganglioside in plasma of patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Shedding of GD2 ganglioside by human neuroblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Ganglioside GD3 shedding by human malignant melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Shedding of human neuroblastoma gangliosides.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Biosynthesis and shedding of murine lymphoma gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Shedding of gangliosides by human medulloblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Gangliosides shed by tumor cells enhance tumor formation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Possible role for glycosphingolipids in the control of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Modulation of the immune response by gangliosides. Inhibition of adherent monocyte accessory function in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Ganglioside GM2 on the K562 cell line is recognized as a target structure by human natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

The role of glycosphingolipids in natural immunity. Gangliosides modulate the cytotoxicity of natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Immunosuppression by human gangliosides. II. Carbohydrate structure and inhibition of human NK activity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Immunosuppression by YAC-1 lymphoma: role of shed gangliosides.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Gangliosides block antigen presentation by human monocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Enhancement of epidermal growth factor signaling and activation of SRC kinase by gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Ganglioside GD1a enhances VEGF-induced endothelial cell proliferation and migration

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Influence of cellular ganglioside depletion on tumor formation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Transfection of glucosylceramide synthase antisense inhibits mouse melanoma formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Differential effects of glycolipid biosynthesis inhibitors on ceramide-induced cell death in neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Glycosphingolipid depletion in fabry disease lymphoblasts with potent inhibitors of glucosylceramide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Critical role for glycosphingolipids in Niemann-Pick disease type C.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

A solvent partition method for microscale ganglioside purification.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Extensive Glycosphingolipid Depletion in the Liver and Lymphoid Organs of Mice Treated withN-Butyldeoxynojirimycin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Improved Inhibitors of Glucosylceramide Synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Intercellular transfer of shed tumor cell gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Angiogenic and angiostatic microenvironment in tumors--role of gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

A mouse B16 melanoma mutant deficient in glycolipids

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900459-2

7 January 2021

10.1016/S0304-3835(03)00459-2

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

14580684